Kimberly Yousey-Hindes, MPH
Epidemiologist 3 and Lecturer in Epidemiology (Microbial Diseases)DownloadHi-Res Photo
Cards
Additional Titles
Program Manager, RESP-NET, Connecticut Emerging Infections Program
Contact Info
Connecticut Emerging Infections Program
One Church St
New Haven, CT 06510
United States
About
Copy Link
Titles
Epidemiologist 3 and Lecturer in Epidemiology (Microbial Diseases)
Program Manager, RESP-NET, Connecticut Emerging Infections Program
Biography
Ms. Yousey-Hindes has worked in the area of infectious disease epidemiology since 2007 for the Council of State and Territorial Epidemiologists and the New York State Department of Health in addition to her current position at the Connecticut Emerging Infections Program (EIP). Within the EIP, Kim has contributed to multiple projects, especially in the area of respiratory disease surveillance. She oversees three population-based surveillance systems in Connecticut as part of CDC's RESP-NET: FluSurv-NET (influenza-associated hospitalizations), RSV-NET (respiratory syncytial virus-associated hospitalizations), and COVID-NET (COVID-19-associated hospitalizations).
Last Updated on May 20, 2025.
Departments & Organizations
Education & Training
- CDC/Council of State and Territorial Epidemiologists Fellow
- New York State Department of Public Health (2008)
- MPH
- Yale School of Public Health, Epidemiology of Microbial Diseases (2007)
- BS
- University of Rochester, Microbiology and Immunology (2004)
Research
Copy Link
Overview
Medical Research Interests
Epidemiology; Infectious Disease Medicine; Influenza, Human; Lyme Disease; Population Surveillance; Rabies; Zoonoses
Public Health Interests
COVID-19; Influenza; Health Equity, Disparities, Social Determinants and Justice; Vaccines
ORCID
0000-0002-9418-575X
Research at a Glance
Yale Co-Authors
Frequent collaborators of Kimberly Yousey-Hindes's published research.
Publications Timeline
A big-picture view of Kimberly Yousey-Hindes's research output by year.
Research Interests
Research topics Kimberly Yousey-Hindes is interested in exploring.
James Meek, MPH
James Hadler, MD, MPH
Laura Bothwell, PhD, MA
Robert Heimer, PhD
75Publications
6,085Citations
Influenza, Human
Population Surveillance
Lyme Disease
Rabies
Zoonoses
Publications
2025
Characteristics of Children Aged 0 to 23 Months Hospitalized With Respiratory Syncytial Virus.
Wang D, Pham H, Chai S, Hoover C, Armistead I, Kawasaki B, Yousey-Hindes K, Meek J, Witt L, Openo K, Brooks A, Rojewski S, Henderson J, Martin E, Mumm E, Salazar-Sanchez Y, Paloma Shaw Y, Keating F, Rowe A, Popham K, Tesini B, Novak A, Sutton M, Schaffner W, Talbot H, Hill M, Zahid H, Havers F, Patton M. Characteristics of Children Aged 0 to 23 Months Hospitalized With Respiratory Syncytial Virus. 2025, 156 PMID: 40707020, DOI: 10.1542/peds.2024-069719.Peer-Reviewed Original ResearchAltmetricMeSH Keywords and ConceptsConceptsRespiratory syncytial virusFeeding tube dependenceProlonged ICU admissionICU admissionTube dependenceClinical characteristicsCardiovascular diseaseSyncytial virusAirway abnormalitiesRisk of severe respiratory syncytial virusAssociated with airway abnormalitiesSevere respiratory syncytial virusRespiratory syncytial virus seasonHospitalized childrenChildren aged 8RSV-associated hospitalizationsPopulation-based surveillance systemAged 0Down syndromeChildren Aged 0Aged 8Aged 0 to 2Severe diseaseChildren 3MonthsIdentification and characterisation of clinically distinct subgroups of adults hospitalised with influenza in the USA: a repeated cross-sectional study
Bozio C, Masalovich S, O'Halloran A, Kirley P, Hoover C, Alden N, Austin E, Meek J, Yousey-Hindes K, Openo K, Witt L, Monroe M, Falkowski A, Leegwater L, Lynfield R, McMahon M, Sosin D, Khanlian S, Anderson B, Spina N, Felsen C, Gaitan M, Lung K, Shiltz E, Thomas A, Schaffner W, Talbot H, Mendez E, Staten H, Reed C, Garg S. Identification and characterisation of clinically distinct subgroups of adults hospitalised with influenza in the USA: a repeated cross-sectional study. EClinicalMedicine 2025, 83: 103207. PMID: 40291348, PMCID: PMC12032903, DOI: 10.1016/j.eclinm.2025.103207.Peer-Reviewed Original ResearchConceptsLaboratory-confirmed influenzaFluSurv-NETClinically distinct subgroupsCase report formsInfluenza seasonClinical courseImpact of influenza vaccinationInfluenza Hospitalization Surveillance NetworkInfluenza-associated hospitalizationsDistinct subgroupsRisk of severe diseaseInvasive mechanical ventilationChronic lung diseaseHeterogeneous clinical presentationCenters for Disease Control and PreventionReport formsDisease Control and PreventionCross-sectional studyInfluenza testingInfluenza vaccineClinical presentationCross-sectional study dataPregnant womenAntiviral treatmentBaseline characteristics
2024
The Burden of All-Cause Mortality Following Influenza-Associated Hospitalizations: Influenza Hospitalization Surveillance Network, 2010–2019
O’Halloran A, Millman A, Holstein R, Olsen S, Cummings C, Chai S, Kirley P, Alden N, Yousey-Hindes K, Meek J, Openo K, Fawcett E, Ryan P, Leegwater L, Henderson J, McMahon M, Lynfield R, Angeles K, Bleecker M, McGuire S, Spina N, Tesini B, Gaitan M, Lung K, Shiltz E, Thomas A, Talbot H, Schaffner W, Hill M, Reed C, Garg S. The Burden of All-Cause Mortality Following Influenza-Associated Hospitalizations: Influenza Hospitalization Surveillance Network, 2010–2019. Clinical Infectious Diseases 2024, 80: e43-e45. PMID: 39495002, PMCID: PMC11912969, DOI: 10.1093/cid/ciae547.Peer-Reviewed Original ResearchCitationsAltmetricConceptsInfluenza-associated hospitalizationsInfluenza-associated deathsIn-HospitalInfluenza Hospitalization Surveillance NetworkClinical characteristics of patientsHospital dischargeLaboratory-confirmed influenzaImpact of influenzaCharacteristics of patientsAll-Cause MortalityMedical conditionsDied in-hospitalFluSurv-NETInfluenza hospitalizationsPost-discharge outcomesClinical characteristicsDeath certificatesOlder patientsPost-dischargeMedian daysPost-discharge deathsInfluenzaPatientsDays post-dischargeCardiovascular diseaseTrends in COVID‐19–Attributable Hospitalizations Among Adults With Laboratory‐Confirmed SARS‐CoV‐2—COVID‐NET, June 2020 to September 2023
Taylor C, Whitaker M, Patton M, Melgar M, Kirley P, Kawasaki B, Yousey‐Hindes K, Openo K, Ryan P, Kim S, Como‐Sabetti K, Solhtalab D, Barney G, Tesini B, Moran N, Sutton M, Talbot H, Olsen K, Havers F. Trends in COVID‐19–Attributable Hospitalizations Among Adults With Laboratory‐Confirmed SARS‐CoV‐2—COVID‐NET, June 2020 to September 2023. Influenza And Other Respiratory Viruses 2024, 18: e70021. PMID: 39496579, PMCID: PMC11534501, DOI: 10.1111/irv.70021.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsAcute Cardiac Events in Hospitalized Older Adults With Respiratory Syncytial Virus Infection
Woodruff R, Melgar M, Pham H, Sperling L, Loustalot F, Kirley P, Austin E, Yousey-Hindes K, Openo K, Ryan P, Brown C, Lynfield R, Davis S, Barney G, Tesini B, Sutton M, Talbot H, Zahid H, Kim L, Havers F, Rowlands J, Spina N, Engesser K, Salazar-Sanchez Y, George A, Staten H, Bleecker M, Leegwater L, Tellez Nunez V, Falkowski A, Felsen C, Licherdell E, St George K, Pacheco F, Desiato J, Labozzo N, Zmek E, Alden N, Strayhorn N, Fawcett E, Surell C, Como-Sabetti K, Mumm E, Bilski K, Markus T, Ndi D, Billings K. Acute Cardiac Events in Hospitalized Older Adults With Respiratory Syncytial Virus Infection. JAMA Internal Medicine 2024, 184: 602-611. PMID: 38619857, PMCID: PMC11019447, DOI: 10.1001/jamainternmed.2024.0212.Peer-Reviewed Original ResearchCitationsAltmetricConceptsRespiratory syncytial virus infectionRespiratory syncytial virusRespiratory syncytial virus seasonAcute cardiac eventsCardiac eventsWeighted estimated prevalenceIn-Hospital DeathAdjusted risk ratiosIntensive care unitClassification of diseasesCross-sectional studyHospitalized adultsCardiac complicationsRSV infectionRSV diseaseLaboratory-confirmed RSV infectionOlder adultsCases of RSV infectionReceipt of invasive mechanical ventilationCardiovascular diseaseIntensive care unit admissionSevere outcomesEstimated prevalenceAcute heart failurePotential cardiac complications
2023
412. Comparison of Outcomes in Pneumonia Patients Hospitalized with COVID-19 and Influenza in Connecticut, 2015-2020
Kim D, Yousey-Hindes K. 412. Comparison of Outcomes in Pneumonia Patients Hospitalized with COVID-19 and Influenza in Connecticut, 2015-2020. Open Forum Infectious Diseases 2023, 10: ofad500.482. PMCID: PMC10679268, DOI: 10.1093/ofid/ofad500.482.Peer-Reviewed Original ResearchConceptsAcute respiratory distress syndromeAge groupsFluSurv-NETRespiratory failureMedian lengthDischarge diagnosisPneumonia casesChest X-ray/CTIntensive care unit admissionEmerging Infections ProgramAcute respiratory failureCare unit admissionLaboratory-confirmed influenzaChronic lung diseaseRespiratory distress syndromeLonger median lengthCoronavirus disease 2019 (COVID-19) pandemicLength of stayChronic metabolic diseaseComparison of outcomesCOVID-19 hospitalizationHospitalized COVID-19COVID-19Disease 2019 pandemicSame age group740. Healthcare-associated invasive Staphylococcus aureus among adults with prior COVID-19-associated hospitalization, 2020
Jackson K, Resler S, Nadle J, Petit S, Yousey-Hindes K, Ray S, Lynfield R, Como-Sabetti K, Bernu C, Dumyati G, Tracy M, Schaffner W, Patel K, Havers F, Biggs H, See I, See I. 740. Healthcare-associated invasive Staphylococcus aureus among adults with prior COVID-19-associated hospitalization, 2020. Open Forum Infectious Diseases 2023, 10: ofad500.801. PMCID: PMC10677147, DOI: 10.1093/ofid/ofad500.801.Peer-Reviewed Original ResearchConceptsCOVID-19-associated hospitalizationLong-term acute care hospitalLong-term care facilitiesCentral venous cathetersMultivariable logistic regressionAcute care hospitalsVenous cathetersCare hospitalCare facilitiesISA infectionsCDC's Emerging Infections ProgramIntensive care unit admissionLogistic regressionInvasive Staphylococcus aureus infectionsEmerging Infections ProgramSurveillance area residentCare unit admissionIntensive care interventionsBody mass indexIntensive care unitStaphylococcus aureus infectionInvasive Staphylococcus aureusBackground COVID-19Grant/research supportHigh death rateCOVID-19–Associated Hospitalizations Among U.S. Adults Aged ≥65 Years — COVID-NET, 13 States, January–August 2023
Taylor C, Patel K, Patton M, Reingold A, Kawasaki B, Meek J, Openo K, Ryan P, Falkowski A, Bye E, Plymesser K, Spina N, Tesini B, Moran N, Sutton M, Talbot H, George A, Havers F, Team C, Team C, Kirley P, Armistead I, Yousey-Hindes K, Oosmanally N, Monroe M, Henderson J, D’Heilly P, Hancock E, Barney G, Bushey S, Billing L, Abdullah N, Schaffner W, Mendez E. COVID-19–Associated Hospitalizations Among U.S. Adults Aged ≥65 Years — COVID-NET, 13 States, January–August 2023. MMWR Morbidity And Mortality Weekly Report 2023, 72: 1089-1094. PMID: 37796744, PMCID: PMC10564325, DOI: 10.15585/mmwr.mm7240a3.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsCOVID-19-associated hospitalizationCOVID-19-Associated Hospitalization Surveillance NetworkCOVID-19-associated hospitalization ratesHospitalization ratesAge groupsIntensive care unit admissionMultiple underlying conditionsSevere COVID-19 diseasePromote early treatmentPositive SARS-CoV-2 testSARS-CoV-2 infectionPrevent SARS-CoV-2 infectionYounger age groupsClinical characteristicsUnit admissionUnderlying conditionEarly treatmentSARS-CoV-2 testingIncreased riskSevere COVID-19-associated outcomesSevere outcomesCOVID-19 hospitalizationElevated riskCOVID-19 diseaseBivalent vaccineSeverity of influenza-associated hospitalisations by influenza virus type and subtype in the USA, 2010–19: a repeated cross-sectional study
Sumner K, Masalovich S, O’Halloran A, Holstein R, Reingold A, Kirley P, Alden N, Herlihy R, Meek J, Yousey-Hindes K, Anderson E, Openo K, Monroe M, Leegwater L, Henderson J, Lynfield R, McMahon M, McMullen C, Angeles K, Spina N, Engesser K, Bennett N, Felsen C, Lung K, Shiltz E, Thomas A, Talbot H, Schaffner W, Swain A, George A, Rolfes M, Reed C, Garg S. Severity of influenza-associated hospitalisations by influenza virus type and subtype in the USA, 2010–19: a repeated cross-sectional study. The Lancet Microbe 2023, 4: e903-e912. PMID: 37769676, PMCID: PMC10872935, DOI: 10.1016/s2666-5247(23)00187-8.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsInfluenza virus typeInfluenza-associated hospitalisationsInfluenza seasonInfluenza B virusICU admissionMechanical ventilationSevere outcomesOdds ratioVirus typeFluSurv-NETECMO useInfluenza vaccineB virusVirus infectionLaboratory-confirmed influenza virus infectionInfluenza Hospitalization Surveillance NetworkInfluenza B virus infectionPopulation-based surveillance systemComplete chart reviewEarly antiviral treatmentHospital-onset casesInfluenza-associated outcomesRepeated cross-sectional studyInfluenza vaccination statusB virus infection
2022
Influenza Antiviral Use in Patients Hospitalized With Laboratory-Confirmed Influenza in the United States, FluSurv-NET, 2015–2019
Tenforde M, Cummings C, O’Halloran A, Rothrock G, Kirley P, Alden N, Meek J, Yousey-Hindes K, Openo K, Anderson E, Monroe M, Kim S, Nunez V, McMahon M, McMullen C, Khanlian S, Spina N, Muse A, Gaitán M, Felsen C, Lung K, Shiltz E, Sutton M, Thomas A, Talbot H, Schaffner W, Price A, Chatelain R, Reed C, Garg S. Influenza Antiviral Use in Patients Hospitalized With Laboratory-Confirmed Influenza in the United States, FluSurv-NET, 2015–2019. Open Forum Infectious Diseases 2022, 10: ofac681. PMID: 36686630, PMCID: PMC9846184, DOI: 10.1093/ofid/ofac681.Peer-Reviewed Original ResearchCitationsAltmetric
News
Copy Link
Get In Touch
Copy Link
Contacts
Mailing Address
Connecticut Emerging Infections Program
One Church St
New Haven, CT 06510
United States
Locations
1 Church Street
Academic Office
Ste 7th Floor
New Haven, CT 06510